Prosecution Insights
Last updated: August 17, 2026

Examiner: CHEONG, CHEOM-GIL

Tech Center 1700 • Art Units: 1643 1645 1672 1674 1699 1793

This examiner grants 64% of resolved cases

Performance Statistics

64.0%
Allow Rate
-1.0% vs TC avg
215
Total Applications
+51.7%
Interview Lift
1204
Avg Prosecution Days
Based on 186 resolved cases, 2023–2026

Rejection Statute Breakdown

3.1%
§101 Eligibility
16.1%
§102 Novelty
24.6%
§103 Obviousness
37.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18429870 Cutibacterium Acnes Biomimetic, Prebiotic, Probiotic and Postbiotic Compositions for Treatment of Skin Conditions Non-Final OA Johnson & Johnson Consumer Inc.
18417720 IMMUNOMODULATING COMPOSITION CONTAINING GASSERI Non-Final OA THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18599008 BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION Non-Final OA WISCONSIN ALUMNI RESEARCH FOUNDATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month